COVID-19: Vaccines and Therapeutics

May 18, 2022
The U.S. Postal Service has delivered about 350 million free at-home tests to households since January.
May 17, 2022
FDA today authorized a single booster dose for children 5-11 who completed the Pfizer vaccine primary series at least five months before.
May 11, 2022
FDA yesterday approved using baricitinib to treat COVID-19 in certain hospitalized adults, and warned not to use a Skippack Medical Lab test.
May 9, 2022
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
May 9, 2022
The guidance is intended to help state policymakers identify and address related issues during and after the public health emergency.
May 6, 2022
Based on an updated analysis, FDA said the risk of thrombosis with thrombocytopenia syndrome warrants limiting the vaccine to certain adults.
May 5, 2022
This webinar rural hospital executives and board leaders discuss how boards can work with all levels within their communities.
May 4, 2022
The report estimates the impact of COVID-19 vaccination during a five-month period shortly after the first vaccine was authorized and recommended for health care workers and elderly people in long-term care facilities.
Apr 28, 2022
Moderna today asked the Food and Drug Administration to authorize for emergency use its COVID-19 vaccine in children aged 6 months through 5 years.
Apr 26, 2022
Starting this week, the Administration will allow all pharmacies in the federal pharmacy program to order free oral antiviral treatments directly from the federal government, the White House announced today.